Open Field Capital is a New York-based SEC-registered investment adviser established in 2003, focused on managing emerging technology portfolios across public equity and venture investments. The firm targets high-growth disruptive technology companies through a flexible, crossover mandate.
43% of their portfolio is in Consumer. Their most common stage is series-b (43% of deals). Average disclosed round size is $127.5M (across 4 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Eridu AI | Unknown | $200M | Jan 2026 |
 Paragraf | Series C | $55M | Aug 2025 |
 Delfi Diagnostics, Inc. | Series B | — | Jul 2022 |
 Delfi | Series B | — | Jul 2022 |
 Neo Cybernetica | Seed | $30M | Feb 2022 |
| Delfi | Series B | $225M | Jan 2022 |
| Delfi | Growth | — | — |
Top Co-Investors
Osage University Partners5 shared
Cowen Healthcare Investments4 shared
Northpond Ventures4 shared
Illumina Ventures4 shared
Menlo Ventures4 shared
T. Rowe Price4 shared
OrbiMed4 shared
AV8 Ventures4 shared
Windham Capital Partners4 shared
Samsara BioCapital4 shared
Foresite Capital4 shared
Rock Springs Capital4 shared
Eli Lilly and Company4 shared
DFJ Growth3 shared
New Enterprise Associates1 shared
B5 Capital1 shared
B Capital1 shared
Cortical Ventures1 shared
MediaTek1 shared
Chamaeleon1 shared
Last updated: 20 October 2026